Home › Funds › SYSTEMATIC FINANCIAL MANAGEMENT LP › JAZZ

SYSTEMATIC FINANCIAL MANAGEMENT LP position in JAZZ

JAZZ PHARMACEUTICALS PLC SHS USD · Health Care

SYSTEMATIC FINANCIAL MANAGEMENT LP reported holding 378,715 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$91.3M, representing 1.82% of its reported portfolio and ranking #3 among its reported holdings. SYSTEMATIC FINANCIAL MANAGEMENT LP has disclosed JAZZ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)378.71K sh
Reported value held$91.26M
Portfolio Weight1.82%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SYSTEMATIC FINANCIAL MANAGEMENT LP's JAZZ position evolved

SYSTEMATIC FINANCIAL MANAGEMENT LP first disclosed a stake in JAZZ in Q3 2023 at 205,774 shares (US$26.6M). The position peaked in Q2 2026 at 378,715 shares, worth US$91.3M. Across 12 filings, SYSTEMATIC FINANCIAL MANAGEMENT LP increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 378,715 shares valued at US$91.3M — a reduction of -28,399 shares quarter over quarter.. Notable position changes include a 33% increase in Q4 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 205.77K $26.64M New
Q4 2023 198.23K $24.38M Reduce
Q1 2024 240.68K $28.98M Add
Q2 2024 254.33K $27.14M Add
Q3 2024 283.98K $31.64M Add
Q4 2024 376.31K $46.34M Add
Q1 2025 386.90K $48.03M Add
Q2 2025 403.51K $42.82M Add
Q3 2025 394.34K $51.97M Reduce
Q4 2025 396.88K $67.47M Add
Q1 2026 407.11K $76.97M Add
Q2 2026 378.71K $91.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JAZZ and 13F data

JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 43 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JAZZ

All JAZZ fund holders →

FAQ

How long has SYSTEMATIC FINANCIAL MANAGEMENT LP held JAZZ?

SYSTEMATIC FINANCIAL MANAGEMENT LP has disclosed JAZZ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SYSTEMATIC FINANCIAL MANAGEMENT LP's current position in JAZZ?

As of Q2 2026, SYSTEMATIC FINANCIAL MANAGEMENT LP holds 378.71K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $91.26M, representing 1.82% of its reported portfolio and ranking #3.

Has SYSTEMATIC FINANCIAL MANAGEMENT LP been buying or selling JAZZ?

In the latest 13F filing (Q2 2026), SYSTEMATIC FINANCIAL MANAGEMENT LP reduced its position in JAZZ. The position peaked in Q2 2026 at 378.71K shares.

Which other funds hold JAZZ?

Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.